| 标题 |
Efficacy and safety of orelabrutinib plus R-CDOP as first-line therapy in diffuse large B-cell lymphoma with high-risk CNS-IPI: a prospective, multicenter, single-arm, phase II study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Frontiers in Oncology 作者:Yiding Guo; Jun Wang; Huyi Lei; Changqian Bao; Panpan Chen; et al 出版日期:2026-10-21 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)